Slevin, M L <br/><br/>
Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1983 
 - 228-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/BF00255772  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Colonic Neoplasms--drug therapy<br/>Humans<br/>Piperazines--administration & dosage<br/>Razoxane--administration & dosage<br/>Rectal Neoplasms--drug therapy